PubMed

Efficacy of salmeterol/fluticasone propionate by GOLD stage of chronic obstructive pulmonary disease: analysis from the randomised, placebo-controlled TORCH study.

Jenkins CR, Jones PW, Calverley PM, Celli B, Anderson JA, Ferguson GT, Yates JC, Willits LR, Vestbo J.

Respir Res. 2009 Jun 30;10:59.PMID: 19566934 [PubMed - indexed for MEDLINE]Related articlesFree article

The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD.

Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS.

Chest. 2007 Dec;132(6):1756-63. Epub 2007 Oct 20.PMID: 17951625 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study.

Celli BR, Thomas NE, Anderson JA, Ferguson GT, Jenkins CR, Jones PW, Vestbo J, Knobil K, Yates JC, Calverley PM.

Am J Respir Crit Care Med. 2008 Aug 15;178(4):332-8. Epub 2008 May 29.PMID: 18511702 [PubMed - indexed for MEDLINE]Related articlesFree article

Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Yates JC, Vestbo J; TORCH investigators.

N Engl J Med. 2007 Feb 22;356(8):775-89.PMID: 17314337 [PubMed - indexed for MEDLINE]Related articlesFree article

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.

Aaron SD, Vandemheen KL, Fergusson D, Maltais F, Bourbeau J, Goldstein R, Balter M, O'Donnell D, McIvor A, Sharma S, Bishop G, Anthony J, Cowie R, Field S, Hirsch A, Hernandez P, Rivington R, Road J, Hoffstein V, Hodder R, Marciniuk D, McCormack D, Fox G, Cox G, Prins HB, Ford G, Bleskie D, Doucette S, Mayers I, Chapman K, Zamel N, FitzGerald M; Canadian Thoracic Society/Canadian Respiratory Clinical Research Consortium.

Ann Intern Med. 2007 Apr 17;146(8):545-55. Epub 2007 Feb 19.PMID: 17310045 [PubMed - indexed for MEDLINE]Related articlesFree article

Effect of fluticasone propionate/salmeterol (250/50 microg) or salmeterol (50 microg) on COPD exacerbations.

Ferguson GT, Anzueto A, Fei R, Emmett A, Knobil K, Kalberg C.

Respir Med. 2008 Aug;102(8):1099-108. Epub 2008 Jul 9.PMID: 18614347 [PubMed - indexed for MEDLINE]Related articles

Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial.

Wouters EF, Postma DS, Fokkens B, Hop WC, Prins J, Kuipers AF, Pasma HR, Hensing CA, Creutzberg EC; COSMIC (COPD and Seretide: a Multi-Center Intervention and Characterization) Study Group.

Thorax. 2005 Jun;60(6):480-7.PMID: 15923248 [PubMed - indexed for MEDLINE]Related articlesFree article

The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide.

Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA; INSPIRE Investigators.

Am J Respir Crit Care Med. 2008 Jan 1;177(1):19-26. Epub 2007 Oct 4.PMID: 17916806 [PubMed - indexed for MEDLINE]Related articlesFree article

Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.

Boonsawat W, Goryachkina L, Jacques L, Frith L.

Clin Drug Investig. 2008;28(2):101-11.PMID: 18211118 [PubMed - indexed for MEDLINE]Related articles

The efficacy and safety of inhaled fluticasone propionate/salmeterol and ipratropium/albuterol for the treatment of chronic obstructive pulmonary disease: an eight-week, multicenter, randomized, double-blind, double-dummy, parallel-group study.

Make B, Hanania NA, ZuWallack R, Kalberg C, Emmett A, Brown CP, Knobil K.

Clin Ther. 2005 May;27(5):531-42.PMID: 15978302 [PubMed - indexed for MEDLINE]Related articles

Prevalence and progression of osteoporosis in patients with COPD: results from the TOwards a Revolution in COPD Health study.

Ferguson GT, Calverley PM, Anderson JA, Jenkins CR, Jones PW, Willits LR, Yates JC, Vestbo J, Celli B.

Chest. 2009 Dec;136(6):1456-65. Epub 2009 Jul 6.PMID: 19581353 [PubMed - indexed for MEDLINE]Related articles

Salmeterol/fluticasone propionate via Diskus once daily versus fluticasone propionate twice daily in patients with mild asthma not previously receiving maintenance corticosteroids.

Chuchalin A, Jacques L, Frith L.

Clin Drug Investig. 2008;28(3):169-81.PMID: 18266402 [PubMed - indexed for MEDLINE]Related articles

Comparable spirometric efficacy of tiotropium compared with salmeterol plus fluticasone in patients with COPD: a pilot study.

Bateman ED, van Dyk M, Sagriotis A.

Pulm Pharmacol Ther. 2008;21(1):20-5. Epub 2006 Oct 13.PMID: 17118684 [PubMed - indexed for MEDLINE]Related articles

Efficacy and tolerability of salmeterol/fluticasone propionate versus montelukast in childhood asthma: A prospective, randomized, double-blind, double-dummy, parallel-group study.

Maspero J, Guerra F, Cuevas F, Gutierrez JP, Soto-Ramos M, Anderton S, Mechali D, Chan R, Pedersen S.

Clin Ther. 2008 Aug;30(8):1492-504.PMID: 18803991 [PubMed - indexed for MEDLINE]Related articles

A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.

Broseghini C, Testi R, Polese G, Tosatto R, Rossi A.

Pulm Pharmacol Ther. 2005;18(2):103-8. Epub 2005 Jan 7.PMID: 15649852 [PubMed - indexed for MEDLINE]Related articles

A short-term comparison of fluticasone propionate/salmeterol with ipratropium bromide/albuterol for the treatment of COPD.

Donohue JF, Kalberg C, Emmett A, Merchant K, Knobil K.

Treat Respir Med. 2004;3(3):173-81.PMID: 15219176 [PubMed - indexed for MEDLINE]Related articles

Development of an economic model to assess the cost effectiveness of treatment interventions for chronic obstructive pulmonary disease.

Spencer M, Briggs AH, Grossman RF, Rance L.

Pharmacoeconomics. 2005;23(6):619-37.PMID: 15960557 [PubMed - indexed for MEDLINE]Related articles

Nebulized arformoterol in patients with COPD: a 12-week, multicenter, randomized, double-blind, double-dummy, placebo- and active-controlled trial.

Baumgartner RA, Hanania NA, Calhoun WJ, Sahn SA, Sciarappa K, Hanrahan JP.

Clin Ther. 2007 Feb;29(2):261-78.PMID: 17472819 [PubMed - indexed for MEDLINE]Related articles

Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results.

Crim C, Calverley PM, Anderson JA, Celli B, Ferguson GT, Jenkins C, Jones PW, Willits LR, Yates JC, Vestbo J.

Eur Respir J. 2009 Sep;34(3):641-7. Epub 2009 May 14.PMID: 19443528 [PubMed - indexed for MEDLINE]Related articles

Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.

Singh D, Brooks J, Hagan G, Cahn A, O'Connor BJ.

Thorax. 2008 Jul;63(7):592-8. Epub 2008 Feb 1.PMID: 18245142 [PubMed - indexed for MEDLINE]Related articles